Immunomedics - News 2012

News

News

February 22, 2012

Immunomedics To Present at Upcoming Healthcare Conferences

February 8, 2012

Immunomedics Announces Second Quarter Fiscal 2012 Results and Clinical Program Developments

January 31, 2012

Immunomedics Awarded Broad Patent For ANTI-CD20 And ANTI-CD22 Combination Therapy

January 20, 2012

Immunomedics Reports Final Results From Phase Ib/II Study of Y-90-labeled Clivatuzumab Tetraxetan in Advanced Pancreatic Cancer

January 18, 2012

Immunomedics Reports Clivatuzumab-Based Blood Test Highly Sensitive And Specific For Early-Stage Pancreatic Cancer

January 12, 2012

Immunomedics Announces Presentations At Gastrointestinal Cancers Symposium Showcasing Advances In Pancreatic Cancer Diagnosis And Therapy.

Archive

News 2011

News 2010

News 2009

News 2008

News 2007

News 2006

News 2005

News 2004

News 2003

News 2002

News 2001

Immunomedics, Inc.
Copyright© 2011
All rights reserved.

300 The American Road
Morris Plains, NJ 07950

Contact Information
Phone No : (973) 605-8200
Fax No : (973) 605-8282

info@immunomedics.com
Contact

Immunomedics Europe
Otto-Roehm-Str. 69
64293 Darmstadt
Germany
Phone: +49 6151 66 715 66 for ordering
+49 6151 66 715 88 for info
Fax: +49 6151 66 715 77
Mail: europe@immunomedics.com